Kissei Pharmaceutical Co., Ltd.

TSE:4547.T

3495 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 75,57967,49365,38169,04463,24572,30273,99871,70771,29770,10870,40062,49464,66964,38762,13764,53861,47564,17964,01360,938
Cost of Revenue 41,15535,11834,14336,32128,34026,73525,87825,07623,58224,06323,18221,14622,89922,49221,71823,72222,79627,98328,28823,530
Gross Profit 34,42432,37531,23832,72334,90545,56748,12046,63147,71546,04547,21841,34841,77041,89540,41940,81638,67936,19635,72537,408
Gross Profit Ratio 0.4550.480.4780.4740.5520.630.650.650.6690.6570.6710.6620.6460.6510.650.6320.6290.5640.5580.614
Reseach & Development Expenses 9,47410,39110,3639,62610,76715,71114,17913,87714,10614,48811,29810,31200000000
General & Administrative Expenses 00000000000000000000
Selling & Marketing Expenses 00000000000000000000
SG&A 20,79020,30419,92319,60721,13322,57723,08023,37922,53022,41722,78122,31500000000
Other Expenses -14358281131171938177681199019169766765158229885943379
Operating Expenses 30,40733,50332,64031,21733,04839,36338,23238,14037,43937,71034,91733,58634,30535,43233,83434,42234,41033,55133,84831,889
Operating Income 4,017-1,129-1,4021,5051,8576,2029,8878,49110,2748,33412,3017,7617,4656,4636,5846,3934,2692,6451,8775,516
Operating Income Ratio 0.053-0.017-0.0210.0220.0290.0860.1340.1180.1440.1190.1750.1240.1150.10.1060.0990.0690.0410.0290.091
Total Other Income Expenses Net 10,43214,82217,9085,9702,7729171,8091,6258612,1311,099230609-13131-3,0362025281,7102,461
Income Before Tax 14,44913,68016,5077,4764,6307,12111,69710,11611,13610,46613,4007,9928,0746,3326,6163,3584,4713,1733,5877,980
Income Before Tax Ratio 0.1910.2030.2520.1080.0730.0980.1580.1410.1560.1490.190.1280.1250.0980.1060.0520.0730.0490.0560.131
Income Tax Expense 3,1593,0463,4752,0981,7411,5862,5982,3512,9403,2774,2832,9503,2882,3232,2301,2852,1221,5661,5383,229
Net Income 11,16010,52812,9215,2852,8175,4819,0457,7268,1657,1659,0935,0194,7694,0044,3712,0612,3251,5712,0454,734
Net Income Ratio 0.1480.1560.1980.0770.0450.0760.1220.1080.1150.1020.1290.080.0740.0620.070.0320.0380.0240.0320.078
EPS 246.58228.3280.19113.2560.3117.33188.24158.74166.89142.14176.6797.5291.3573.7880.5237.9842.8628.9337.3186.47
EPS Diluted 246.58228.3280.19113.2560.3117.33188.24158.74166.89142.14176.6797.5291.3573.7880.5237.1640.1628.9337.3175.53
EBITDA 8,2714,6284,1345,9335,8179,97513,54211,80413,63312,03315,38511,03810,82810,00210,52410,9128,7046,1136,0479,028
EBITDA Ratio 0.1090.0690.0630.0860.0920.1380.1830.1650.1910.1720.2190.1770.1670.1550.1690.1690.1420.0950.0940.148